E
Coeptis Therapeutics Holdings, Inc. COEP
$8.39 $0.11871.44% NASDAQ
Recommendation
Prev Close
$8.27
Volume
4,910
Avg Vol (90D)
294,328
Market Cap
$27.83M
Dividend & Yield
--
52-Week Range
$2.31 - $13.70
P/E (TTM)
--
EPS (TTM)
-$5.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders
5/6/2025 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
5/1/2025 - Globe Newswire
Coeptis Therapeutics Holdings Inc trading resumes
4/30/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading resumes
4/30/2025 - The Fly
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
4/30/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
4/30/2025 - The Fly
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
4/30/2025 - Globe Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP
4/28/2025 - PR Newswire
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
4/25/2025 - Business Wire
Coeptis Therapeutics Holdings Inc trading resumes
4/25/2025 - The Fly
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
4/25/2025 - Globe Newswire
Coeptis Therapeutics Holdings Inc trading halted, news pending
4/25/2025 - The Fly
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Short Interest Update
4/18/2025 - Ticker Report
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
4/17/2025 - Globe Newswire
NUBURU Announces Strategic Corporate Update Focused on Defense & Security, Advanced Technologies, and Growth Initiatives
4/15/2025 - Business Wire
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest
3/14/2025 - Ticker Report
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
3/11/2025 - Globe Newswire
COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
3/7/2025 - Globe Newswire
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Decrease in Short Interest
3/5/2025 - Ticker Report
Top 9 AI News and Ratings Sending Shockwaves
2/21/2025 - Insider Monkey
Coeptis Therapeutics Holdings Inc trading resumes
2/20/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading resumes
2/20/2025 - The Fly
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
2/20/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
2/20/2025 - The Fly
COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
2/20/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$9.05M
EBIT (TTM)
-$10.05M
Net Income (TTM)
-$9.81M
Balance Sheet
Total Assets (Q)
$8.91M
Total Debt (Q)
$1.40M
Total Liabilities (Q)
$5.04M
Book Value Per Share (Q)
$1.51
Cash Flow
Cash from Operations (TTM)
-$6.65M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$5.71M
Net Change in Cash (TTM)
-$936.30K
Filings
Filing Date
Friday, March 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
-0.49
7-Day Total Return
-15.44%
30-Day Total Return
-10.85%
60-Day Total Return
-28.85%
90-Day Total Return
98.78%
Year to Date Total Return
41.94%
1-Year Total Return
10.52%
2-Year Total Return
-72.96%
3-Year Total Return
-95.83%
5-Year Total Return
--
52-week Low
Dec 31, 2024 - $2.31
52-week High
Jan 30, 2025 - $13.70
Valuation
Market Cap
$27.83M - Nano Cap
Enterprise Value
$29.38M
Price/Sales (TTM)
--
Price/Book (Q)
5.49
Dividends and Shares
Shares Outstanding
2.05M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
coeptistx.com
Phone Number
724 934 6467
Address
105 Bradford Road
Wexford, PA 15090
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and... more
NASDAQ 05/08/2025 9:54AM Eastern Quotes delayed